Abstract:Yen-Jen Chen, 1, 2, &ast Ming-Che Chang, 3, &ast Kai-Ming Jhang, 4, &ast Wen-Fu Wang, 4, &ast Yi-Cheng Liao 1 1 Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan; 2 Department of Psychiatry, Yuanlin Christian Hospital, Changhua, Taiwan; 3 Department of Nuclear Medicine, Changhua Christian Hospital, Changhua, Taiwan; 4 Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan &astThese authors contributed equally to this work Correspondence: Yi-Cheng Liao, Department of Psychiatry, Changhua Christian Hospital, 135, Nan-Xiao St, Changhua, 500, Taiwan, Tel +886 4 7238595 ext. 7160, Fax +886 4-7251004, Email Background: To compare short-term cognitive outcomes among groups with and without neuropsychiatric symptoms (NPSs) or antipsychotic prescription and to determine which disease status or treatment modality is associated with relatively faster cognitive decline. Methods: We retrospectively analyzed a prospective cohort of patients diagnosed with dementia and mild cognitive impairment. All participants were evaluated using the Cognitive Abilities Screening Instrument (CASI) during their initial clinical assessments and at the annual follow-up. The dependent variable was annual delta CASI. Multivariate linear regression analysis was used to assess the degree of association between NPS, antipsychotic use, and cognitive decline after adjusting for confounding factors. Neuropsychiatric symptoms were examined individually to determine their predictive value for cognitive decline. Results: A total of 407 (N = 407) patients were included in the study. NPSs, rather than antipsychotic use, led to faster cognitive decline. A higher baseline NPI total score predicted a significantly faster decline in CASI scores (1-year delta CASI = − 0.22, 95% CI = − 0.38~ − 0.05, p = 0.010). Specific items (delusions, agitation, depression, anxiety, euphoria, and apathy) in the NPS significantly increased cognitive decline. Conclusion: Certain neuropsychiatric symptoms, rather than antipsychotic use, lead to faster cognitive decline in a dementia collaborative care model. Checking for and providing appropriate interventions for NPS in people with dementia and their caregivers are highlighted. Keywords: neuropsychiatric symptoms, antipsychotics, cognitive decline, cognitive abilities screening instrument, dementia collaborative care Neuropsychiatric symptoms (NPSs) are behavioral (eg aberrant motor behavior) and psychological (eg delusion or hallucination) symptoms. They hold a high prevalence in patients with dementia and occur frequently during the course of cognitive decline. In addition to dementia caused by Alzheimer's disease (AD), NPSs are common across various types of dementia. 1–3 In our previous study on the institutionalization risks for patients with dementia in Taiwan, we found that the presence of NPSs at entry into dementia collaborative care is a significant predictor. 4 Institutionalization partially reflects dementia progression 5 and provides indirect evidence of the speed of progression. Surveillance of longitudinal changes in dementia severity are essential for providing individualized care plans. A longitudinal survey of neuropsychological functions predicts the prognosis of patients with cognitive impairment. 6 Factors associated with faster neurocognitive progression warrant further confirmation and may serve as a pivotal role for continuous care directions. A case management model in dementia care has been reported to reduce the prevalence of neuropsychiatric symptoms. 7,8 The use of psychotropic medications is significantly associated with a high severity of NPS. 9 Decreasing the severity of NPS can be achieved with both a cognitive-behavioral approach 10 and psychotropic use. 11 Increasing evidence has shown that the conversion rate of mild cognitive impairment (MCI) to dementia is higher in patients with more severe NPS. 12,13 Certain types of NPSs are predictors of progression to AD. 14 The prevalence of NPSs is associated with an increased rate of cognitive decline, even in older adults without dementia. 15 Antipsychotic use has been postulated to predict cognitive decline; 16 however, confounding effect of the indication should be taken into account. NPSs are significant factors for families to recognize the progression of dementia. 17 NPS severity is associated with caregiver stress and therapeutic outcomes. 18 Furthermore, neuropsychiatric symptoms are associated with h -Abstract Truncated-

Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients

Prevalence of Neuropsychiatric Symptoms Across the Declining Memory Continuum: an Observational Study in a Memory Clinic Setting

A Risk Factor Analysis of Cognitive Impairment in Elderly Patients with Chronic Diseases in a Chinese Population

Neuropsychiatric symptoms as prognostic makers for the elderly with mild cognitive impairment: a meta-analysis

P3-459: Neuropsychiatric Features in Alzheimer's Disease and Mild Cognitive Impairment in Memory Clinic

The Incidence and Burden of Risk Factors for Mild Cognitive Impairment in Older Rural Chinese Persons.

Sociodemographic Factors Predict Incident Mild Cognitive Impairment: A Brief Review and Empirical Study.

Characterizing Mild Cognitive Impairment in Prodromal Parkinson’s Disease: A Community‐based Study in China

Neuropsychiatric symptoms associated multimodal brain networks in Alzheimer's disease

Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study

Characteristics of neuropsychiatric symptoms among individuals with Alzheimer's disease in a memory clinic setting

Neuropsychiatric Symptoms Predict Faster Cognitive Decline in Dementia Collaborative Care Than Antipsychotic Use

Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline

Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline

Association Of Neuropsychiatric Symptoms And Sub-Syndromes With Cognitive Impairment In Community-Dwelling Asian Elderly

An investigation of neuropsychiatric symptoms, contextual factors, and antidepressant treatment as risk factors for dementia development in people with mild cognitive impairment

Prevalence, Clinical Correlates, Cognitive Trajectories, and Dementia Risk Associated with Mild Behavioral Impairment in Asians.

Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression

Behavioral and Psychological Symptoms in Alzheimer's Disease.

Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment